Noun:

কোনো দেহনালির সংকীর্ণ অবস্থা,

steatosis's Usage Examples:

Fatty liver disease (FLD), also known as hepatic steatosis, is a condition where excess fat builds up in the liver.

(NAFL, simple steatosis) to non-alcoholic steatohepatitis (NASH).

These diseases begin with fatty accumulation in the liver (hepatic steatosis).

Although steatosis (fatty liver disease) will develop in any individual who consumes a large.

It can also result in hepatic steatosis.

Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes.

Focal fatty liver (FFL) or focal steatosis is localised or patchy process of lipid accumulation in the liver.

intake of ketogenic amino acids lysine and threonine may induce hepatic steatosis, a major cause of non-alcoholic fatty liver disease.

stain, that shows microvesicular steatosis (or small collections of fat within the liver cells).

The microvesicular steatosis usually spares zone one of the.

classical effect of prolonged use both in adult and paediatric population is steatosis.

For example, with the hepatitis C virus (HCV), liver steatosis is characteristic enough of the virus that it may be used to help identify.

and consists of liver fibrosis and inflammation assessment, as well as steatosis grading.

symptoms of hepatic steatosis and polycystic ovary syndrome.

Leptin can also be used to reverse insulin resistance and hepatic steatosis, to cause reduced.

This results in cardiac steatosis, an abnormal retention of lipids within a cell.

Despite massive steatosis, overexpression of cardiac PLIN5.

knockout mice are resistant to high fat diet induced obesity and liver steatosis.

available evidence indicates it does not improve outcomes of hepatic steatosis.

Liver stiffness is usually indicative of fibrosis or steatosis (fatty liver disease), which are in turn indicative of numerous disease.

"Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities.

In rats, ursolic acid ameliorated high-fat diet-induced hepatic steatosis and improved metabolic disorders in high-fat diet-induced non-alcoholic.

Fatty liver disease (hepatic steatosis) is a reversible condition where large vacuoles of triglyceride fat accumulate.